Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience-Reference-Cited by-同舟云学术

Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience

Published:2024-02-22 Issue:6 Volume:11 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Lu Brian¹^ORCID,Ha David²³,Shen Sa⁴,Ferguson Toll Jessica³,Kim Ailin¹,Kim Sarah¹,Mui Emily²³,Deresinski Stan²³,Holubar Marisa²³^ORCID,Alegria William²³

Affiliation:

1. Department of Pharmacy, Stanford Health Care , Stanford, California , USA

2. Department of Quality, Stanford Health Care , Stanford, California , USA

3. Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University , Stanford, California , USA

4. Quantitative Sciences Unit, School of Medicine, Stanford University , Stanford, California , USA

Abstract

Abstract Combination antifungal therapy for invasive mucormycosis remains controversial and is inconsistently defined in prior studies. In a cohort of patients with immunocompromised status and invasive mucormycosis, we found no difference in 6-week mortality with up-front or salvage combination therapy as compared with monotherapy.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae103/56740733/ofae103.pdf

Reference16 articles.

1. Challenges in the diagnosis and treatment of mucormycosis;Skiada;Med Mycol,2018

2. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium;Cornely;Lancet Infect Dis,2019

3. Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae;Rodríguez;Antimicrob Agents Chemother,2008

4. Posaconazole mono- or combination therapy for treatment of murine zygomycosis;Ibrahim;Antimicrob Agents Chemother,2009

5. Mucormycosis in hematopoietic cell transplant recipients and in patients with hematological malignancies in the era of new antifungal agents;Miller;Open Forum Infect Dis,2021